Jump to content

Welcome to the new Traders Laboratory! Please bear with us as we finish the migration over the next few days. If you find any issues, want to leave feedback, get in touch with us, or offer suggestions please post to the Support forum here.

  • Welcome Guests

    Welcome. You are currently viewing the forum as a guest which does not give you access to all the great features at Traders Laboratory such as interacting with members, access to all forums, downloading attachments, and eligibility to win free giveaways. Registration is fast, simple and absolutely free. Create a FREE Traders Laboratory account here.

Stevenvegas

Stevenvegas Trades

Recommended Posts

big big day. BWIH up nicely off news and now DCMT which closed strong signs huge Pan Asia agreement!

 

Closed strong at .58

 

Document Capture Announces Milestone Pan-Asia Licensing Agreement

http://biz.yahoo.com/bw/090209/20090209006334.html?.v=1

 

Monday February 9, 4:01 pm ET

Far Reaching Sales Agreement between DCT and China-Based Syscan Technology Holdings

 

SAN JOSE, Calif.--(BUSINESS WIRE)--Document Capture Technologies, Inc. (OTCBB:DCMT - News), an IP-driven worldwide leader in the design, development and sale of next-generation portable scanning technologies, today announced a major product sales licensing agreement with China-based company Syscan Technology Holdings (STH).

 

 

STH is a leading manufacturer and provider of 2D barcode scanning technology, products and application solutions throughout China. For ten years STH and one of its wholly owned subsidiaries have worked closely with DCT: manufacturing its products exclusively. This logical broadening of that relationship is expected to result in the expansion of the international market for DCT mobile scanners.

 

“This is a major threshold event for Document Capture as it provides significant pan-Asian market expansion for DCT’s products directly into China and Southeast Asia as well as India, Pakistan and Malaysia,” said David P. Clark, Chief Executive Officer of DCT. “The growth of the security and financial sectors in these markets, as well as those more established in Korea, Japan, and Singapore are potentially some of the fastest growing in the world. To move into these areas with such a strong partner as STH is a major step in DCT’s corporate and revenue growth.”

 

The one-year renewable agreement covers DCT’s six DocketPORT® series products, as well as future offerings currently in development. DCT will also provide STH with Software Development Kits (SDK’s) covering PC, Linux, Mac, and Win CE operating systems. In addition the two companies will work together in the defending of the IP behind these devices worldwide.

 

As a shareholder, Syscan Technology Holdings currently owns over 3 million shares of DCT common stock. It is expected that the expanded relationship between the two companies will produce mutual opportunity for ongoing market development and expansion in Asia and beyond.

 

“This is a win-win joining of forces in the manufacturing sale and market expansion of mobile scanners globally.” Cheung Wei, Chairman of STH commented. “We believe there is great opportunity in China and other emerging markets.”

 

DCT’s commitment to product innovation has resulted in demand-driven products at the forefront of the paper-to-digital revolution. The proliferation of paper-to-digital green initiatives, high security demands and accelerated financial transactions require innovative ways to digitally capture, authenticate, store, share, and manage information.

Share this post


Link to post
Share on other sites

APPY news - Update

 

Update: AspenBio Pharma to Host Conference Call to Discuss Preliminary Results of the AppyScore FDA Clinical Study on Jan. 21 at 9:00 AM ET

 

CASTLE ROCK, CO--(MARKET WIRE)--Jan 20, 2009 -- AspenBio Pharma, Inc. (NasdaqCM:APPY - News), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has changed the time for the conference call previously scheduled for Thursday, January 22, 2009 to now be held earlier, on Wednesday, January 21 at 9:00 a.m. Eastern time.

 

The company management will discuss initial preliminary data from its Food and Drug Administration clinical trial of AppyScore, the world's first blood-based test as an aid in the diagnosis of human appendicitis. They will also discuss status of the FDA approval, product development and commercialization of AppyScore.

 

AspenBio's Vice-Chairman Greg Pusey will host the call, with presentations by president and CEO, Richard G. Donnelly, the company's new executive chairman, Daryl J. Faulkner and Dr. John Bealer, the co-inventor of AppyScore. This will be followed by a question and answer period.

 

Please call the conference telephone number 5-10 minutes prior to the start time:

 

 

Date: Wednesday, January 21, 2009

Time: 9:00 a.m. Eastern time (6:00 a.m. Pacific time)

Dial in number, U.S./Canada Toll-free: 1-800-896-8445

International (Toll): 1-785-830-1916

Conference ID: 7ASPENBIO

 

An operator will register your name and organization and ask you to wait until the call begins. If you have any difficulty connecting with the conference call, please contact the Liolios Group at (949) 574-3860.

 

A simultaneous webcast and replay of the call will be accessible via this link: http://viavid.net/dce.aspx?sid=00005C74.

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Topics

  • Posts

    • Date: 29th March 2024. GBPUSD Analysis: The Pound Trades Higher But For How Long? The global Stocks Markets are closed due to Easter Friday (Good Friday). The NASDAQ continued to follow the sideways trend while other indices again rose. The SNP500 reaches an all-time high, but the NASDAQ remains under pressure from Tesla, Meta and Apple. The Euro continues to trade lower against all major currencies including the US Dollar, Euro and Japanese Yen. The British Pound is the best performing currency during this morning’s Asian session. However, investors are largely fixing their attention on this afternoon’s Core PCE Price Index. GBPUSD – The Pound Trades Higher but For How Long? The GBPUSD is slightly higher than the day’s open and is primary due to the Pound’s strong performance. At the moment, the British Pound is increasing in value against all major currencies. However, the US Dollar Index is also trading 0.10% higher and for this reason there is a slight conflict here. If investors wish to avoid this conflict, the EURUSD is a better option. This is because, the Euro depreciating against the whole currency market avoiding the “tug-of-war” scenario. The GBPUSD is trading slightly lower than the 2-month’s average price and is trading at 49.10 on the RSI. For this reason, the price of the exchange is at a “neutral” level and is signalling neither a buy nor a sell. The day’s price action and future signals are possibly likely to be triggered by this afternoon’s Core PCE Price Index. Analysts expect the Core PCE Price Index to read 0.3% which is slightly lower than the previous month but will result in the annual figure remaining at 2.85%. The PCE rate is different to the inflation rate and the Fed aims for a rate between 1.5% to 2.00%. Therefore, even if the annual rate remains at 2.85%, as analysts expect, it would be too high for the Fed. If the rate increases, even if only slightly, the US Dollar can again renew bullish momentum and the stock market can come under pressure. This includes the SNP500. Investors are focused on the publication of data on the UK’s gross domestic product (GDP) for the last quarter of 2023: the quarterly figures decreased by 0.3%, and 0.2% over the past 12-months. This confirms the state of a shallow recession and the need for stimulation. The data, combined with a cooling labor market and a steady decline in inflation, increase the likelihood that the Bank of England will soon begin interest rate cuts. In the latest meeting the Bank of England representatives did not see any members vote for a hike. USA500 – The SNP500 Rises to New Highs, But Cannot Hold Onto Gains! The price of the SNP500 rises to an all-time high, before correcting 0.33% and ending the day slightly lower than the open price. Nonetheless, the index performs better than the NASDAQ which came under pressure from Tesla, Meta and Apple which hold a higher weight compared to the SNP500. For the SNP500, these 3 stocks hold a weight of 9.25%, whereas the 3 stocks make up 14.63% of the NASDAQ. The SNP500 is also supported by ExxonMobil’s gains due to higher energy prices. The market will remain closed on Friday due to Easter. However, the market will reopen on Monday for the US and investors can expect high volatility. Investors will also need to take into consideration how the PCE Price Index and the changed value of the US Dollar is likely to affect the stock market next week. Always trade with strict risk management. Your capital is the single most important aspect of your trading business. Please note that times displayed based on local time zone and are from time of writing this report. Click HERE to access the full HFM Economic calendar. Want to learn to trade and analyse the markets? Join our webinars and get analysis and trading ideas combined with better understanding on how markets work. Click HERE to register for FREE! Click HERE to READ more Market news. Michalis Efthymiou Market Analyst HFMarkets Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in FX and CFDs products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.
    • MT4 is good and will be good until their parent company keep updating the software, later mt4 users will have to switch to mt5.
    • $SOUN SoundHound AI stock at 5.91 support area , see https://stockconsultant.com/?SOUN
    • $ELEV Elevation Oncology stock bull flag breakout watch , see https://stockconsultant.com/?ELEV
    • $AVDX AvidXchange stock narrow range breakout watch above 13.32 , see https://stockconsultant.com/?AVDX
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.